Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease
(Reuters) -MeiraGTx Holdings has signed a deal with Eli Lilly, potentially worth over $475 million,...
10th November, 2025
(Reuters) -MeiraGTx Holdings has signed a deal with Eli Lilly, potentially worth over $475 million,...
10th November, 2025
BERLIN (Reuters) -Taiwan's chip industry has become an indispensible part of the global economy and...
10th November, 2025
(Reuters) -Grab Holdings will invest $60 million in remote driving firm Vay Technology, the Singapor...
10th November, 2025
(Reuters) -AI startup Tsavorite Scalable Intelligence said on Monday it has secured more than $100 m...
10th November, 2025

By Forrest Crellin PARIS (Reuters) -Italian small-modular-reactor startup Newcleo is considering dev...
10th November, 2025
(Reuters) -Novo Nordisk has partnered with India's Emcure Pharmaceuticals to exclusively distribute...
10th November, 2025
LONDON (Reuters) -Britain is sending experts and equipment to Belgium to help it combat disruptive d...
9th November, 2025
SHANGHAI (Reuters) -The Chinese government said on Saturday it is waiting for concrete actions by th...
8th November, 2025
By Wen-Yee Lee HSINCHU, Taiwan (Reuters) -Nvidia CEO Jensen Huang on Saturday said the semiconductor...
8th November, 2025
(Reuters) -Pfizer has submitted a sweetened bid for Metsera, an obesity drug developer, as its fight...
8th November, 2025
(Reuters) -Ukrainian President Volodymyr Zelenskiy on Friday appointed a new commander responsible f...
7th November, 2025

In today’s fast-moving markets, tools make the difference between reaction and readiness. But not al...
7th November, 2025